91 related articles for article (PubMed ID: 19426599)
1. [Expression of IMP3 in osteosarcoma and its clinical significance].
Li KH; Huang YP; Zhang J; Li GJ; Li SH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):426-7. PubMed ID: 19426599
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma.
Do SI; Kim YW; Park HR; Park YK
Oncol Res; 2008; 17(6):269-72. PubMed ID: 19192721
[TBL] [Abstract][Full Text] [Related]
3. NPRL2 is an independent prognostic factor of osteosarcoma.
Gao Y; Wang J; Fan G
Cancer Biomark; 2012-2013; 12(1):31-6. PubMed ID: 23321467
[TBL] [Abstract][Full Text] [Related]
4. Correlations Between Hector Battifora Mesothelial-1 (HBME-1) Expression and Clinical Pathological Characteristics and Prognosis of Osteosarcoma Patients.
Zhao YX; Gao ST; Wang JQ; Yao WT; Wang YS; Guo CL
Med Sci Monit; 2017 Feb; 23():665-672. PubMed ID: 28163298
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of Src and p-Src expression in patients with osteosarcoma.
Hu C; Deng Z; Zhang Y; Yan L; Cai L; Lei J; Xie Y
Med Sci Monit; 2015 Feb; 21():638-45. PubMed ID: 25725252
[TBL] [Abstract][Full Text] [Related]
6. High expression of periostin is dramatically associated with metastatic potential and poor prognosis of patients with osteosarcoma.
Hu F; Wang W; Zhou HC; Shang XF
World J Surg Oncol; 2014 Sep; 12():287. PubMed ID: 25224568
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis.
Xie Y; Huang J; Wu M; Zhou Y
J Cancer Res Ther; 2018; 14(4):892-895. PubMed ID: 29970672
[TBL] [Abstract][Full Text] [Related]
8. IMP3 expression in human ovarian cancer is associated with improved survival.
Noske A; Faggad A; Wirtz R; Darb-Esfahani S; Sehouli J; Sinn B; Nielsen FC; Weichert W; Buckendahl AC; Röske A; Müller B; Dietel M; Denkert C
Int J Gynecol Pathol; 2009 May; 28(3):203-10. PubMed ID: 19620937
[TBL] [Abstract][Full Text] [Related]
9. Expression of b-FGF and endostatin and their clinical significance in human osteosarcoma.
Xu CJ; Song JF; Su YX; Liu XL
Orthop Surg; 2010 Nov; 2(4):291-8. PubMed ID: 22009965
[TBL] [Abstract][Full Text] [Related]
10. IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas.
Riener MO; Fritzsche FR; Clavien PA; Pestalozzi BC; Probst-Hensch N; Jochum W; Kristiansen G
Hum Pathol; 2009 Oct; 40(10):1377-83. PubMed ID: 19467694
[TBL] [Abstract][Full Text] [Related]
11. The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis.
Chen P; Wang SJ; Wang HB; Ren P; Wang XQ; Liu WG; Gu WL; Li DQ; Zhang TG; Zhou CJ
J Mol Histol; 2012 Feb; 43(1):63-70. PubMed ID: 22042095
[TBL] [Abstract][Full Text] [Related]
12. IMP3 expression in serous tumors of the ovary.
Chisté M; Alexis J; Recine M
Appl Immunohistochem Mol Morphol; 2014 Oct; 22(9):658-62. PubMed ID: 25279713
[TBL] [Abstract][Full Text] [Related]
13. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
14. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract][Full Text] [Related]
15. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis.
Ibrahim DA; Abouhashem NS
Pathol Res Pract; 2016 Apr; 212(4):288-93. PubMed ID: 26874572
[TBL] [Abstract][Full Text] [Related]
17. Correlations of expressions of IMP3 and VEGF with stage of osteosarcoma, microvascular density and pulmonary metastasis.
Kong X; Xu L; Cao X
J BUON; 2020; 25(5):2438-2443. PubMed ID: 33277867
[TBL] [Abstract][Full Text] [Related]
18. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.
Jiang Z; Chu PG; Woda BA; Rock KL; Liu Q; Hsieh CC; Li C; Chen W; Duan HO; McDougal S; Wu CL
Lancet Oncol; 2006 Jul; 7(7):556-64. PubMed ID: 16814207
[TBL] [Abstract][Full Text] [Related]
19. THE INFLUENCE AND REGULATORY MECHANISM OF Y-BOX BINDING PROTEIN 1 IN OSTEOSARCOMA AND ITS SIGNIFICANCE.
Zhou WP; Liu X; Yang Y; Liu YF
J Biol Regul Homeost Agents; 2015; 29(2):485-91. PubMed ID: 26122241
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.
Takizawa K; Yamamoto H; Taguchi K; Ohno S; Tokunaga E; Yamashita N; Kubo M; Nakamura M; Oda Y
Hum Pathol; 2016 Sep; 55():30-8. PubMed ID: 27137988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
